良好的实验动物给药和采血(包括途径和体积)规范指南.doc

上传人:cn****1 文档编号:563723870 上传时间:2023-03-01 格式:DOC 页数:27 大小:196KB
返回 下载 相关 举报
良好的实验动物给药和采血(包括途径和体积)规范指南.doc_第1页
第1页 / 共27页
良好的实验动物给药和采血(包括途径和体积)规范指南.doc_第2页
第2页 / 共27页
良好的实验动物给药和采血(包括途径和体积)规范指南.doc_第3页
第3页 / 共27页
良好的实验动物给药和采血(包括途径和体积)规范指南.doc_第4页
第4页 / 共27页
良好的实验动物给药和采血(包括途径和体积)规范指南.doc_第5页
第5页 / 共27页
点击查看更多>>
资源描述

《良好的实验动物给药和采血(包括途径和体积)规范指南.doc》由会员分享,可在线阅读,更多相关《良好的实验动物给药和采血(包括途径和体积)规范指南.doc(27页珍藏版)》请在金锄头文库上搜索。

1、A Good Practice Guide to the Administration of Substances and Removal of Blood,Including Routes and Volumes良好的实验动物给药和采血(包括途径和体积)规范指南Karl-Heinz Diehl1, Robin Hull2, David Morton3, Rudolf Pfister4, Yvon Rabemampianina5,David Smith6,*, Jean-Marc Vidal7 and Cor van de Vorstenbosch 81Aventis, PO Box 1140

2、, D35001 Marburg, Germany德国马尔堡市35001区1140信箱安万特公司2N I B S C, Blanch Lane, South Miimms, Potters Bar, Hertfordshire EN6 3QG英国赫特福德郡EN6 3QG波特斯巴镇South Miimms布兰奇道英国国家生物制品检定所3The University of Birmingham, Medical School, Edgbaston, Birmingham B15 2TT英国伯明翰市B15 2TT艾吉马斯顿伯明翰大学医学院 4Novartis Pharma AG, CH-4002 B

3、asel, Switzerland瑞士巴塞尔CH-4002诺华制药公司5Centre de Recherche Pfizer, Etablissement dAmboise, Z1 Poce-sur-Cisse-BP 159 37401 Amboise Cedex, France法国Amboise Cedex Z1 Poce-sur-Cisse-BP 159 37401 Etablissement dAmboise 辉瑞研究中心6AstraZeneca R&D Charnwood, Bakewell Road, Loughborough, Leics LE11 5RH英国莱斯特郡LE11 5R

4、H拉夫堡市贝克韦尔路Charnwood阿斯利康研究中心7Aventis, 102 Route de Noisy, 95235 Romainville Cedex, France法国Romainville Cedex 95235 Noisy路102号安万特公司8N V Organon, PO Box 20, 5340 BH Oss, Netherlands荷兰BH Oss5340 20号信箱欧加农公司Key words: blood volumes; blood removal; administration substances; laboratory animals; refinement.

5、关键词:血容量;采血;给药;实验动物;简化This article is the result of an initiative between the European Federation of Pharmaceutical Industries Associations (EFPIA) and the European Centre for the Validation of Alternative Methods (ECVAM).Its objectives are to provide the researcher in the safety evaluation laborator

6、y with an up-to-date, easyto-use set of data sheets to aid in the study design process whilst at the same time affording maximum welfare considerations to the experimental animals.该文章为欧盟制药工业协会(EFPIA)和欧洲替代动物实验方法验证中心(ECVAM)之间的初步结果。其目的在于为安全性评价实验室的研究者提供最新的易于使用的数据库以帮助研究设计过程,同时最大可能地考虑到实验动物的福利。Although thi

7、s article is targeted at researchers in the European Pharmaceutical Industry, it is considered that the principles underpinning the data sets and refinement proposals are equally applicable to all those who use these techniques on animals in their research, whether in research institutes,universitie

8、s or other sectors of industry. The implications of this article may lead to discussion with regulators, such as those responsible for pharmacopoeial testing.尽管该文章针对的是欧洲制药工业界的研究者,但支撑该数据库的基本原理及改进建议同样适用于所有在他们的研究中使用这些动物实验技术的人,不论是研究所、大学或其它行业中的研究者。There are numerous publications dealing with the administ

9、ration of test substances and the removal of blood samples, and many laboratories also have their own in-house guidelines that have been developed by custom and practice over many years. Within European Union Directive 86/609EEC1 we have an obligation to refine experiments to cause the minimum amoun

10、t of stress. We hope that this article will provide background data useful to those responsible for protocol design and review.有关供试品给予和采血的出版物众多,且许多实验室在多年的经验和实践基础之上亦发展了它们自己的内部指南。在欧盟化妆品标准86/609EEC中,我们有义务简化实验以最小化动物的紧张程度。我们希望该文能够对那些负责方案设计和审核的研究者提供有用的背景数据。This guide is based on peer-reviewed publications

11、 whenever possible, but where this is not possible we have used in-house data and the experience of those on the working party (as well as helpful comments submitted by the industry) for a final opinion. The guide also addresses the continuing need to refine the techniques associated with the admini

12、stration of substances and the withdrawal of blood, and suggests ways of doing so. Data-sharing between laboratories should be encouraged to avoid duplication of animal work, as well as sharing practical skills concerning animal welfare and scientific problems caused by overdosing in some way or ano

13、ther. The recommendations in this guide refer to the normal animal, and special consideration is needed, for instance, during pregnancy and lactation.Interpretation of studies may be confounded when large volumes are administered or excessive sampling employed, particularly if anaesthetics are used.

14、 Copyright 2001 John Wiley & Sons, Ltd.该文章基于历年所有可能收集到的同行评议出版物,但我们未能够收集到的内部数据和那些工作组的经验(以及行业提交的有用的注释)除外。该指南亦强调了持续性简化与给药和采血有关的技术的必要性,并且建议该如何去进行这方面的工作。应该鼓励实验室间的数据共享以避免重复性动物研究,以及共享在某些方法或其它情况下的“药物过量”所引起的与动物福利有关的实际技术和科学问题。有必要对该指南中涉及到的“正常动物”要求进行特殊考虑,如妊娠和哺乳期间的动物。当给药体积较大或过度采样时对研究结果的诠释可能会令人感到困惑,特别是使用麻醉动物时。GOOD

15、 PRACTICE GUIDE FOR ADMINISTRATION OF SUBSTANCES良好的给药规范指南Introduction引言Dosing of experimental animals is necessary for a variety of scientific investigations and to meet regulatory demands. The pharmaceutical industry, in particular,has investigated the levels of dosing compatible with animal welfar

16、e and valid science.2 In the preclinical stage of the safety evaluation of new drugs it is normal practice to use multiples of the effective dosein order to attempt to establish the necessary safety margins. Where chemicals are of low toxicity or are only poorly soluble in acceptable formulations, a large volume may be required to be given to individual animals to satisfy both scientific and regulatory requirem

展开阅读全文
相关资源
正为您匹配相似的精品文档
相关搜索

最新文档


当前位置:首页 > 行业资料 > 家居行业

电脑版 |金锄头文库版权所有
经营许可证:蜀ICP备13022795号 | 川公网安备 51140202000112号